Glaxo kidney cancer drug - Votrient approved to treat patients with advanced renal cell carcinoma. <a href="http://www.marketwatch.com/story/fda-approves-glaxosmithkline-renal-cancer-drug-2009-10-19?siteid=yhoof2" rel="nofollow" target="_blank">http://www.marketwatch.com/story/fda-approves-glaxosmithkline-renal-cancer-drug-2009-10-19?siteid=yhoof2</a>